MarketResearchReports.Biz
announces addition of new report"
Binge Eating Disorder - Pipeline Review, H1 2016 "to
its database.
Global
Markets Directs, Binge
Eating Disorder - Pipeline Review, H1 2016,
provides an overview of the Binge Eating Disorder pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Binge Eating Disorder, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Binge Eating Disorder and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Binge Eating Disorder
-
The report reviews pipeline therapeutics for Binge Eating Disorder by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Binge Eating Disorder
therapeutics and enlists all their major and minor projects
-
The report assesses Binge Eating Disorder therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Binge Eating Disorder
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Binge Eating Disorder
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Binge Eating Disorder pipeline depth and focus of Indication
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Binge
Eating Disorder Overview 6
Therapeutics
Development 7
Pipeline
Products for Binge Eating Disorder - Overview 7
Binge
Eating Disorder - Therapeutics under Development by Companies 8
Binge
Eating Disorder - Pipeline Products Glance 9
Late
Stage Products 9
Clinical
Stage Products 10
Early
Stage Products 11
Unknown
Stage Products 12
Binge
Eating Disorder - Products under Development by Companies 13
Binge
Eating Disorder - Companies Involved in Therapeutics Development 14
Heptares
Therapeutics Limited 14
Omeros
Corporation 15
Opiant
Pharmaceuticals, Inc. 16
Polleo
Pharma Limited 17
Sunovion
Pharmaceuticals Inc. 18
Teva
Pharmaceutical Industries Ltd. 19
Binge
Eating Disorder - Therapeutics Assessment 20
Assessment
by Monotherapy Products 20
Assessment
by Target 21
Assessment
by Mechanism of Action 23
Assessment
by Route of Administration 25
Assessment
by Molecule Type 27
Drug
Profiles 28
armodafinil
- Drug Profile 28
Product
Description 28
Mechanism
of Action 28
R&D
Progress 28
dasotraline
hydrochloride - Drug Profile 30
Product
Description 30
Mechanism
of Action 30
R&D
Progress 30
naloxone
hydrochloride - Drug Profile 32
Product
Description 32
Mechanism
of Action 32
R&D
Progress 32
OMS-527
- Drug Profile 34
Product
Description 34
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment